JP2015535839A5 - - Google Patents

Download PDF

Info

Publication number
JP2015535839A5
JP2015535839A5 JP2015533635A JP2015533635A JP2015535839A5 JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5 JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5
Authority
JP
Japan
Prior art keywords
alkyl
carboxylic acid
compound
amino
heteroarylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015533635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015535839A (ja
JP6298998B2 (ja
Filing date
Publication date
Priority claimed from EP12306196.2A external-priority patent/EP2712866A1/en
Application filed filed Critical
Publication of JP2015535839A publication Critical patent/JP2015535839A/ja
Publication of JP2015535839A5 publication Critical patent/JP2015535839A5/ja
Application granted granted Critical
Publication of JP6298998B2 publication Critical patent/JP6298998B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015533635A 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体 Expired - Fee Related JP6298998B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306196.2A EP2712866A1 (en) 2012-10-01 2012-10-01 1,2,4-triazine derivatives for the treatment of viral infections
EP12306196.2 2012-10-01
PCT/EP2013/070488 WO2014053516A1 (en) 2012-10-01 2013-10-01 1,2,4-triazine derivatives for the treatment of viral infections.

Publications (3)

Publication Number Publication Date
JP2015535839A JP2015535839A (ja) 2015-12-17
JP2015535839A5 true JP2015535839A5 (enExample) 2016-11-10
JP6298998B2 JP6298998B2 (ja) 2018-03-28

Family

ID=46982496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533635A Expired - Fee Related JP6298998B2 (ja) 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体

Country Status (21)

Country Link
US (1) US9416114B2 (enExample)
EP (2) EP2712866A1 (enExample)
JP (1) JP6298998B2 (enExample)
KR (1) KR102138393B1 (enExample)
CN (1) CN104812747B (enExample)
AU (1) AU2013326579B2 (enExample)
BR (1) BR112015007310B1 (enExample)
CA (1) CA2886630C (enExample)
CL (1) CL2015000787A1 (enExample)
EA (1) EA026236B1 (enExample)
ES (1) ES2616496T3 (enExample)
IL (1) IL237871A (enExample)
IN (1) IN2015DN03327A (enExample)
MX (1) MX348229B (enExample)
MY (1) MY182558A (enExample)
NZ (1) NZ706354A (enExample)
PH (1) PH12015500724B1 (enExample)
SG (1) SG11201502522WA (enExample)
UA (1) UA114644C2 (enExample)
WO (1) WO2014053516A1 (enExample)
ZA (1) ZA201502240B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA027792B1 (ru) 2011-04-08 2017-09-29 Янссен Сайенсиз Айрлэнд Юси Производные пиримидина для лечения вирусных инфекций
CN104066733A (zh) 2011-11-09 2014-09-24 爱尔兰詹森研发公司 用于治疗病毒感染的嘌呤衍生物
SG11201408542VA (en) 2012-07-13 2015-02-27 Janssen Sciences Ireland Uc Macrocyclic purines for the treatment of viral infections
KR102280595B1 (ko) 2012-10-10 2021-07-22 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염 및 다른 질환 치료를 위한 피롤로[3,2-d]피리미딘 유도체
CN105051018B (zh) 2012-11-16 2019-09-20 爱尔兰詹森科学公司 用于治疗病毒性感染的杂环的经取代的2-氨基-喹唑啉衍生物
CN105189468B (zh) 2013-02-21 2018-10-30 爱尔兰詹森科学公司 用于治疗病毒性感染的2-氨基嘧啶衍生物
MX366481B (es) 2013-03-29 2019-07-09 Janssen Sciences Ireland Uc Deaza-purinonas macrociclicas para el tratamiento de infecciones virales.
DK3004074T3 (da) 2013-05-24 2018-01-29 Janssen Sciences Ireland Uc Pyridonderivater til behandling af virusinfektioner og yderligere sygdomme
NO3030563T3 (enExample) 2013-06-27 2018-01-06
MX368625B (es) 2013-07-30 2019-10-08 Janssen Sciences Ireland Uc Derivados de tieno[3,2-d]pirimidinas para el tratamiento de infecciones virales.
CA3027471A1 (en) 2016-07-01 2018-01-04 Janssen Sciences Ireland Unlimited Company Dihydropyranopyrimidines for the treatment of viral infections
CN109790154B (zh) * 2016-09-29 2023-06-23 爱尔兰詹森科学公司 用于治疗病毒感染和另外的疾病的嘧啶前药
TW201945003A (zh) 2018-03-01 2019-12-01 愛爾蘭商健生科學愛爾蘭無限公司 2,4-二胺基喹唑啉衍生物及其醫學用途
MX2021009496A (es) 2019-02-08 2021-09-08 Progeneer Inc Complejo de colesterol-agonista del receptor 7 u 8 tipo larga distancia, y uso del mismo.
JP2023516372A (ja) 2020-03-02 2023-04-19 プロジェニア インコーポレイテッド 病原菌外壁成分基盤の生病原体模倣ナノ粒子及びその製造方法
JP7690222B2 (ja) 2020-08-04 2025-06-10 プロジェニア インコーポレイテッド 動力学的制御が可能なアジュバントを含むmRNAワクチン
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
JP2023536954A (ja) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド 活性化部位が一時的に不活性化したトール様受容体7または8作用薬と機能性薬物の結合体およびその用途
WO2024151953A1 (en) * 2023-01-15 2024-07-18 Viradem Inc. Compounds and methods for treating diseases caused by sars-cov-2 and other coronaviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
ATE283855T1 (de) 1996-07-03 2004-12-15 Sumitomo Pharma Neue purinderivate
CA2311742C (en) 1997-11-28 2009-06-16 Sumitomo Pharmaceuticals Co., Ltd. 6-amino-9-benzyl-8-hydroxypurine derivatives
CA2575002C (en) * 2004-08-10 2015-01-20 Janssen Pharmaceutica N.V. Hiv inhibiting 1,2,4-triazin-6-one derivatives
BRPI0611435A2 (pt) 2005-05-04 2010-09-08 Pfizer Ltd derivados de 2-amido-6-amino-8-oxopurina, composições farmacêuticas, uso e processo de preparo dos mesmos
JP4850911B2 (ja) * 2005-09-01 2012-01-11 エフ.ホフマン−ラ ロシュ アーゲー P2x3およびp2x2/3モジュレーターとしてのジアミノピリミジン
RU2352565C1 (ru) * 2007-10-08 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" 3-амино-6-ароилметил-5-гидрокси-1,2,4-триазины и способ их получения
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
WO2012067269A1 (en) * 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease

Similar Documents

Publication Publication Date Title
JP2015535839A5 (enExample)
HRP20200538T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
SI2906563T1 (en) Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases
PH12019502370A1 (en) Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same
JP2015537020A5 (enExample)
NZ627036A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HRP20180447T1 (hr) Derivati kinazolina za liječenje virusnih infekcija i drugih bolesti
JP2016530259A5 (enExample)
EP3954679A3 (en) Amide compounds for the treatment of hiv infections
JP2016519165A5 (enExample)
JP2017523225A5 (enExample)
JP2016540742A5 (enExample)
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
JP2014514360A5 (enExample)
JP2016522172A5 (enExample)
JP2017533968A5 (enExample)
JP2015509535A5 (enExample)
JP2016518305A5 (enExample)
JP2014506907A5 (enExample)
JP2015520140A5 (enExample)
MY187617A (en) Bridged ring compounds as hepatitis c virus (hcv) inhibitors and pharmaceutical applications thereof
HRP20171720T1 (hr) Derivati pirolo [3,2-d] pirimidina za liječenje virusnih infekcija i drugih bolesti
JP2015535847A5 (enExample)
JP2017517565A5 (enExample)
JP2017533263A5 (enExample)